跳至主要内容
临床试验/NCT05947786
NCT05947786已完成不适用

Mpox Paediatric and Adolescent Clinical Study

PENTA Foundation11 个研究点 分布在 7 个国家目标入组 1,108 人开始时间: 2023年3月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,108
试验地点
11
主要终点
Proportion of participants with severe mpox.

研究概览

简要总结

The goal of this multicentre, observational study on mpox in infants, children and adolescents is to increase knowledge about mpox infection and its associated disease in infants, children and adolescents. This will be done through the development of a harmonized system that will allow standard collection of information on demographics, clinical symptoms, clinical course, treatments and outcomes. The study will be carried out in three potential phases: Phase 1 entails the rapid development of an online paediatric registry collecting anonymised data from routine care on infants, children and adolescents with laboratory-confirmed mpox virus infection. If warranted, the study will proceed to Phase 2, an enhanced observational study of children and adolescents with confirmed mpox virus infection, if more detailed prospective data collection would aid the public health response. There is also the potential to initiate Phase 3, comprising of nested sub-studies to investigate specific research questions in this population.

详细描述

The primary objective of this multicentre observational study is to use a harmonised data system for the standard data collection and analysis to describe the presentation, clinical course and outcomes of laboratory-confirmed mpox virus infection in infants, children and adolescents by:

  1. monitoring the temporal and geographical distribution of mpox infection in the paediatric and adolescent population, including in specific paediatric/adolescent groups, such as those with underlying conditions or with congenital mpox;
  2. describing the epidemiology and clinical presentation of the disease, including outcomes of treatment administered as part of routine care;
  3. describing high risk populations , including identifying factors associated with severe disease and death.

Phase 1 consists of the rapid development of an online registry for standard collection of data on infants, children and adolescents with laboratory-confirmed mpox infection, including adolescent girls who acquired mpox in pregnancy, and infants who acquired mpox through vertical transmission. All data will be fully anonymised, allowing rapid implementation in many countries without the need for ethics approval, where applicable.

If additional data collection would aid the public health response, the investigators might additionally include a second phase (Phase 2) of the project, with the aim to implement an enhanced prospective observational study of children and adolescents with confirmed mpox infection. This part of the project, if activated, will be a consented study collecting detailed data over the course of the disease.

Phase 3: initiation of nested sub-studies within the consented observational study (Phase 2) to investigate specific research questions in this population, including collection of samples, where necessary, for analysis and/or storage in a biobank. Each sub-study will require its own protocol and informed consent.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • all infants, children and adolescents aged <18 years at the time of mpox diagnosis, with laboratory-confirmed mpox infection, as per national guidelines;
  • mothers of eligible infants who are diagnosed with mpox at 28days or less are included in the study to collect maternal data on pregnancy and delivery

排除标准

  • adolescents aged over 18 years old at mpox diagnosis.

结局指标

主要结局

Proportion of participants with severe mpox.

时间窗: Throughout study completion, expected 2 years from study start.

Severe mpox infection as measured by, for example, mortality, ICU admission, receipt of interventions

Proportion of Participants With Severe Mpox.

时间窗: Throughout the study period. Participants are enrolled over a period of 2 years 7 months, participants' outcomes are recorded at 28 days.

Severe mpox infection as measured by, for example, mortality, ICU admission, receipt of interventions

次要结局

  • Number of infants born to women infected with mpox in pregnancy, who are vertically infected with mpox.(Throughout study completion, expected 2 years from study start.)
  • Number of Infants Born to Women Infected With Mpox in Pregnancy, Who Are Vertically Infected With Mpox.(Throughout the study period. Participants are enrolled over a period of 2 years 7 months, participants' outcomes are recorded at 28 days.)

研究者

发起方
PENTA Foundation
申办方类型
Network
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验